Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit related to misleading statements and omissions concerning the company's cow's milk-based formula, Enfamil, which allegedly increased the risk of NEC in preterm infants [1][3]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 13, 2021, to July 28, 2024 [3]. - Allegations include that Reckitt failed to disclose the increased risk of NEC for preterm infants consuming Enfamil, the impact on sales, and the exposure to legal claims, leading to materially false and misleading statements about the company's business and prospects [3]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of August 4, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements or omissions [5].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit alleging that the company made materially false and misleading statements about its cow's milk-based formula, Enfamil, which is linked to increased risks for preterm infants [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from January 13, 2021, to July 28, 2024 [1]. - The allegations include that Reckitt failed to disclose the increased risk of necrotizing enterocolitis (NEC) for preterm infants consuming Enfamil, which could impact sales and expose the company to legal claims [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by August 4, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the status of the case [2]. Group 3: Firm's Mission - The Gross Law Firm aims to protect investors' rights against deceit and illegal business practices, ensuring companies adhere to responsible business practices [3].

Financial Performance - Reckitt Benckiser expects higher revenue growth from its core brands this year [1] - Reckitt Benckiser initiated a £1 billion share buyback program [1]

Core Viewpoint - Scott+Scott Attorneys at Law LLP has filed a securities class action lawsuit against Reckitt Benckiser Group PLC, alleging misleading statements regarding the risks associated with its cow's milk-based formula, Enfamil, during the Class Period from January 13, 2021, to July 28, 2024 [1][3]. Group 1: Lawsuit Details - The lawsuit asserts claims under the Securities Exchange Act of 1934, specifically §§10(b) and 20(a), on behalf of individuals who purchased Reckitt American Depositary Shares (ADSs) during the Class Period [1]. - The case is titled Elevator Constructors Union Local No. 1 Annuity & 401(K) Fund v. Reckitt Benckiser Group PLC, et al., Case No. 1:25-cv-4708 [1]. Group 2: Allegations Against Reckitt - The Class Action alleges that Reckitt failed to disclose that preterm infants consuming its Enfamil formula were at an increased risk of developing necrotizing enterocolitis (NEC) [3]. - It is claimed that Reckitt did not adequately warn investors about the potential impact on sales and legal exposure related to the NEC risk [3]. Group 3: Market Reactions - On March 15, 2024, following a jury verdict in a related NEC lawsuit, Reckitt's ADS price fell by $1.87, or nearly 14%, from $13.31 to $11.44 per share [4]. - On July 29, 2024, after another jury verdict against Abbott Laboratories regarding NEC, Reckitt's ADS price dropped by $1.02, or nearly 9%, from $11.66 to $10.64 per share [5].

NEW YORK, July 22, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADSs") of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 through July 28, 2024, both dates inclusive (the "Class Period"), of the important August 4, 2025 lead plaintiff deadline.So What: If you purchased Reckitt ADSs you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.What to ...

Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group PLC, alleging that the company made misleading statements regarding the health risks associated with its Enfamil infant formula, particularly for preterm infants [3][4]. Group 1: Class Action Details - The class action represents investors who purchased Reckitt Benckiser securities between January 13, 2021, and July 28, 2024, with a deadline for filing a lead plaintiff motion set for August 4, 2025 [1]. - The lawsuit claims that Reckitt Benckiser failed to disclose the increased risk of Necrotizing Enterocolitis (NEC) for preterm infants consuming its cow's milk-based formula [3]. Group 2: Legal Allegations and Impact - A jury found Mead Johnson, a subsidiary of Reckitt Benckiser, negligent in a case related to NEC, resulting in a $60 million verdict on March 15, 2024, which led to a nearly 14% drop in Reckitt Benckiser's American Depositary Shares (ADSs) [4]. - Following a related case that awarded $495 million in damages for NEC caused by a competing formula, Reckitt Benckiser's ADSs fell nearly 9% on July 29, 2024 [5]. Group 3: Company Background - Reckitt Benckiser is a U.K.-based global consumer goods company that acquired Mead Johnson Nutrition for $19.7 billion in 2017 [2].

Core Viewpoint - A class action securities lawsuit has been filed against Reckitt Benckiser Group plc, alleging securities fraud that negatively impacted investors between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Reckitt Benckiser Group plc made false statements regarding the safety of its cow's milk-based formula, Enfamil, which allegedly increased the risk of NEC in preterm infants [2]. - It is alleged that the company concealed the impact of these risks on its sales and exposure to legal claims, leading to materially false and misleading positive statements about its business and operations [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 4, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

NEW YORK, July 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTC PINK: RBGLY) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team:http ...

NEW YORK, July 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTC PINK: RBGLY). Shareholders who purchased shares of RBGLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CLASS PERIOD: January 13, 2021 to July 28, 2024 ALLEGATIONS: The complaint alleges that during the class period, Defendants issue ...

NEW YORK, July 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTC PINK: RBGLY) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team:http ...